Biomarkers · Chemical
Hepatitis B Surface Antibody Level, Pre/Post HBIG Infusion
- LOINC codes
- 5193-8
- Tests that measure Hepatitis B Surface Antibody Level, Pre/Post HBIG Infusion
- Quest Diagnostics 5
Ranges
Each lab publishes a reference range for the population groups it tests, usually the middle 95% of results. These intervals describe that population, not an optimal or healthy target. How ranges differ
Quest Diagnostics, HBV Triple Screen Panel with Reflexes 39170
| Population | Interval |
|---|---|
| Interpretation | See Laboratory Report |
| Hepatitis B Surface Antigen | Non-Reactive |
| Hepatitis B Core Antibody, Total | Non-Reactive |
| Hepatitis B Surface Ab, Quant | ≥10 mIU/mL |
Tests
Check the catalog code, specimen, method and preparation for every test that measures Hepatitis B Surface Antibody Level, Pre/Post HBIG Infusion. Select up to five tests to compare them side by side.
Quest Diagnostics 5 tests
Single-analyte tests
Hepatitis B Surface Antibody Immunity, Quantitative 8475
Serum · Fasting not stated · Turnaround Set up: Daily; Report available: 2 days
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
- Reference notes
- ≥10 mIU/mL
Hepatitis B Surface Antibody Level, Pre/Post HBIG Infusion 34000
Serum · Fasting not stated · Turnaround Set up: Mon-Sat
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
- Reference notes
- ≥10 mIU/mL
Panels that include this biomarker
HBV Triple Screen Panel with Reflexes 39170
2 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
- Collection
- Dietary supplements containing biotin may interfere in assays and may skew analyte results to be either falsely high or falsely low. For patients receiving the recommended daily doses of biotin, draw samples at least 8 hours following the last biotin supplementation. For patients on mega-doses of biotin supplements, draw samples at least 72 hours following the last biotin supplementation.
Pre-biologic/biosimilar Screen Panel, HCV/HBV with Reflexes and QFT 1 Tube 37616
2 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- See individual tests
- Collection
- Collect 6 mL of blood by venipuncture into a lithium heparin (green-top) tube. Hold tube at room temperature (17-25° C.) for between 15 minutes and 3 hours after blood collection. Refrigerate at 2-8° C. Note: The Centers for Disease Control and Prevention (CDC) has provided guidance on clinical considerations for tuberculosis (TB) testing such as QuantiFERON®-TB Gold Plus in conjunction with COVID-19 mRNA vaccines. Please refer to the QuantiFERON®-TB Gold Plus FAQ link (https://education.questdiagnostics.com/faq/FAQ204) for more detailed information on the latest CDC guidelines regarding TB testing and COVID-19 vaccines. Dietary supplements containing biotin may interfere in assays and may skew analyte results to be either falsely high or falsely low. For patients receiving the recommended daily doses of biotin, draw samples at least 8 hours following the last biotin supplementation. For patients on mega-doses of biotin supplements, draw samples at least 72 hours following the last biotin supplementation.
- Reference notes
- See individual tests
Pre-biologic/biosimilar Screen Panel, HCV/HBV with Reflexes and QFT 4 Tubes 37620
3 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- See individual tests
- Collection
- Note: Specimen collection locations >3350 feet above sea level should use the QuantiFERON® collection kit designed for "High Altitude" (tubes with a gold ring on tube top) For each patient, collect 1 mL of blood by venipuncture directly into each of the 4 QFT-PLUS blood collection tubes. These tubes should be at 17-25° C at the time of draw. If a "butterfly needle" is being used, a "purge" tube should be used to ensure that the tubing is filled with blood prior to the QFT-Plus tubes being used. Immediately after filling the tubes, shake them 10 times just firmly enough to ensure the entire surface of the tube is coated with blood, to solubilize antigens on tube walls. Each of the four tubes must be transferred to a 37° C plus or minus 1° C incubator as soon as possible and within 16 hours of collection for 16-24 hours. If the blood is not incubated immediately after collection, re-mixing of the tubes by inverting 10 times must be performed immediately prior to incubation. The specimen rack should sit off the floor of the incubator and the tubes should be upright. Following incubation either: A. Centrifuge each of the 4 incubated collection tubes for 15 minutes at 2000-3000 RCF(G). Label with patient name, identification number, and date of collection. Deliver to Quest Diagnostics at 2-8° C. Samples will be stable for 28 days at 2-8° C (refrigerated). *OR* B. Immediately transport the 4 collection tubes to Quest Diagnostics between 4 and 27° C. Samples will be stable for 72 hours at 4-27° C (refrigerated or at room temperature). The Centers for Disease Control and Prevention (CDC) has provided guidance on clinical considerations for tuberculosis (TB) testing such as QuantiFERON®-TB Gold Plus in conjunction with COVID-19 mRNA vaccines. Please refer to the QuantiFERON®-TB Gold Plus FAQ link (https://education.questdiagnostics.com/faq/FAQ204) for more detailed information on the latest CDC guidelines regarding TB testing and COVID-19 vaccines. Dietary supplements containing biotin may interfere in assays and may skew analyte results to be either falsely high or falsely low. For patients receiving the recommended daily doses of biotin, draw samples at least 8 hours following the last biotin supplementation. For patients on mega-doses of biotin supplements, draw samples at least 72 hours following the last biotin supplementation.
- Reference notes
- See individual tests
0 of 5 tests selected
Pick one moreSources
Quest Diagnostics test catalog
5 tests: codes, specimens, methods, preparation and reference intervals.
LOINC 5193-8
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for Hepatitis B Surface Antibody Level, Pre/Post HBIG Infusion
Registered studies that measure Hepatitis B Surface Antibody Level, Pre/Post HBIG Infusion, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.